These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2568138)

  • 1. Pharmacology of nicotine.
    Grenhoff J; Svensson TH
    Br J Addict; 1989 May; 84(5):477-92. PubMed ID: 2568138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity and variability of the effects of nicotine on different cortical regions of the brain - therapeutic and toxicological implications.
    Toledano A; Alvarez MI; Toledano-Díaz A
    Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):180-206. PubMed ID: 20528766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular mechanisms of action of nicotine in the CNS.
    Barik J; Wonnacott S
    Handb Exp Pharmacol; 2009; (192):173-207. PubMed ID: 19184650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple brain pathways and receptors underlying tobacco addiction.
    Rose JE
    Biochem Pharmacol; 2007 Oct; 74(8):1263-70. PubMed ID: 17826746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nicotine dependence--medico-biological aspects].
    Dybing E; Sanner T
    Tidsskr Nor Laegeforen; 2002 Jan; 122(3):302-5. PubMed ID: 11894603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine: from molecular mechanisms to behaviour.
    Wonnacott S; Sidhpura N; Balfour DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):53-9. PubMed ID: 15661626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of neuronal nicotinic acetylcholine recceptors: effects of acute and chronic nicotine.
    Kellar KJ; Dávila-García MI; Xiao Y
    Nicotine Tob Res; 1999; 1 Suppl 2():S117-20; discussion S139-40. PubMed ID: 11768167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and synaptic mechanisms of nicotine addiction.
    Mansvelder HD; McGehee DS
    J Neurobiol; 2002 Dec; 53(4):606-17. PubMed ID: 12436424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic modulation of neuronal networks: from receptors to cognition.
    Mansvelder HD; van Aerde KI; Couey JJ; Brussaard AB
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):292-305. PubMed ID: 16001117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nicotine and nicotinic receptors on anxiety and depression.
    Picciotto MR; Brunzell DH; Caldarone BJ
    Neuroreport; 2002 Jul; 13(9):1097-106. PubMed ID: 12151749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine as a discriminative stimulus: a neurobehavioral approach to studying central cholinergic mechanisms.
    Rosecrans JA
    J Subst Abuse; 1989; 1(3):287-300. PubMed ID: 2535609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological aspects of the link between smoking and depression.
    Quattrocki E; Baird A; Yurgelun-Todd D
    Harv Rev Psychiatry; 2000 Sep; 8(3):99-110. PubMed ID: 10973935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction.
    Rahman S; López-Hernández GY; Corrigall WA; Papke RL
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):422-41. PubMed ID: 19128201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular mechanisms of nicotine addiction.
    Dani JA; De Biasi M
    Pharmacol Biochem Behav; 2001 Dec; 70(4):439-46. PubMed ID: 11796143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal nicotine or cocaine exposure: which one is worse?
    Slotkin TA
    J Pharmacol Exp Ther; 1998 Jun; 285(3):931-45. PubMed ID: 9618392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.
    Balfour DJ; Fagerström KO
    Pharmacol Ther; 1996; 72(1):51-81. PubMed ID: 8981571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco smoking and nicotine neuropsychopharmacology: some future research directions.
    Domino EF
    Neuropsychopharmacology; 1998 Jun; 18(6):456-68. PubMed ID: 9571654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural pharmacology of nicotine: multiple mechanisms.
    Stolerman IP
    Br J Addict; 1991 May; 86(5):533-6. PubMed ID: 1650269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments.
    Besson M; Guiducci S; Granon S; Guilloux JP; Guiard B; Repérant C; Faure P; Pons S; Cannazza G; Zoli M; Gardier AM; Maskos U
    Psychopharmacology (Berl); 2016 Sep; 233(18):3297-314. PubMed ID: 27385416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine as a discriminative stimulus: a neurobiobehavioral approach to studying central cholinergic mechanisms.
    Rosecrans JA
    J Subst Abuse; 1989; 1(3):287-300. PubMed ID: 7580220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.